Home Newsfeeds Cowen & Co. Maintains Outperform on TransMedics Group, Raises Price Target to $45

Cowen & Co. Maintains Outperform on TransMedics Group, Raises Price Target to $45

Cowen & Co. analyst Joshua Jennings maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and raises the price target from $39 to $45.

byBenzinga Newsdesk

July 26, 2022

1 minute read

Cowen & Co. analyst Joshua Jennings maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and raises the price target from $39 to $45.

EF Hutton Reiterates Buy on KLX Energy Services Hldgs, Maintains $30 Price Target

By Benzinga Newsdesk

March 10, 8:36 AM

EF Hutton analyst Ignacio Bernaldez reiterates KLX Energy Services Hldgs (NASDAQ:KLXE) with a Buy and maintains $30 price target.

KLXE

What’s Going On With ProShares UltraPro Short QQQ ETF Today

By Anusuya Lahiri

May 5, 11:45 AM

ProShares UltraPro Short QQQ (NASDAQ: SQQQ) is trading lower today as investors dump the U.S. treasury bills for higher-risk, higher-reward investments following a surge in treasury yields.

AAPL

Guardant Health Has ‘Underlying Business Strength’ Says This Bullish Analyst

By Priya Nigam

September 27, 12:17 PM

Shares of Guardant Health Inc (NASDAQ: GH) climbed during the premarket trading session and morning on Wednesday.

Sturm Ruger & Co Q4 EPS $1.06 Beats $0.98 Estimate, Sales $149.20M Beat $134.93M Estimate

By Bill Haddad

February 22, 6:24 PM

Sturm Ruger & Co (NYSE:RGR) reported quarterly earnings of $1.06 per share which beat the analyst consensus estimate of $0.98 by 8.16 percent. This is a 50.47 percent decrease over earnings of $2.14 per share from the

RGR

Cowen & Co. Maintains Outperform on TransMedics Group, Raises Price Target to $45

Related Posts

EF Hutton Reiterates Buy on KLX Energy Services Hldgs, Maintains $30 Price Target

What’s Going On With ProShares UltraPro Short QQQ ETF Today

Guardant Health Has ‘Underlying Business Strength’ Says This Bullish Analyst

Sturm Ruger & Co Q4 EPS $1.06 Beats $0.98 Estimate, Sales $149.20M Beat $134.93M Estimate